Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ensysce Biosciences (ENSC) Total Debt (2020 - 2022)

Historic Total Debt for Ensysce Biosciences (ENSC) over the last 3 years, with Q4 2022 value amounting to $140148.0.

  • Ensysce Biosciences' Total Debt fell 9684.42% to $140148.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $140148.0, marking a year-over-year decrease of 9684.42%. This contributed to the annual value of $140148.0 for FY2022, which is 9684.42% down from last year.
  • As of Q4 2022, Ensysce Biosciences' Total Debt stood at $140148.0, which was down 9684.42% from $2.2 million recorded in Q3 2022.
  • Ensysce Biosciences' 5-year Total Debt high stood at $4.4 million for Q4 2021, and its period low was $140148.0 during Q4 2022.
  • Its 3-year average for Total Debt is $1.4 million, with a median of $566268.0 in 2020.
  • Per our database at Business Quant, Ensysce Biosciences' Total Debt surged by 27340.11% in 2021 and then tumbled by 9684.42% in 2022.
  • Quarter analysis of 3 years shows Ensysce Biosciences' Total Debt stood at $566268.0 in 2020, then soared by 684.25% to $4.4 million in 2021, then plummeted by 96.84% to $140148.0 in 2022.
  • Its Total Debt was $140148.0 in Q4 2022, compared to $2.2 million in Q3 2022 and $360797.0 in Q2 2022.